Search Results - "Pittman, K. B."

Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study by PITTMAN, K. B, OLVER, I. N, PRICE, T. J, KOCZWARA, B, KOTASEK, D, PATTERSON, W. K, KEEFE, D. M, KARAPETIS, C. S, PARNIS, F. X, MOLDOVAN, S, YEEND, S. J

“…Cancer of unknown primary site (CUP) represents up to 5% of all cancer diagnoses and is associated with poor survival. We have performed a prospective…”
Get full text

A phase I study to determine the safety, tolerability and maximum tolerated dose of green-lipped mussel (Perna canaliculus) lipid extract, in patients with advanced prostate and breast cancer by Sukumaran, S., Pittman, K.B., Patterson, W.K., Dickson, J., Yeend, S., Townsend, A., Broadbridge, V., Price, T.J.

“…Background: This was a phase I trial to determine the maximum tolerated dose (MTD) of a marine lipid extract from the New Zealand green-lipped mussel (Perna…”
Get full text

Influence of hairy vetch seed germination and maturation on weediness in subsequent crops by Pittman, K B, Barney, J N, Cahoon, C W, Flessner, M L, Liebman, Matt

“…Summary Hairy vetch is a widely adopted cover crop in the United States. However, hairy vetch can become weedy in subsequent crops as seeds germinate after the…”
Get full text

Treatment of metastatic breast cancer with continuous infusional 5 fluorouracil by Karapetis, C. S., Patterson, W. K., Pittman, K. B., Kotasek, D., Sage, R. E.

“…Background: Single agent continuous infusional 5 fluorouracil (CI‐5FU) via a central venous catheter (CVC) is usually reserved for breast cancer patients who…”
Get full text

Non-haematological toxicity limiting the application of sequential high dose chemotherapy in patients with advanced breast cancer by Pittman, K B, To, L B, Bayly, J L, Olweny, C L, Abdi, E A, Carter, M L, Malycha, P, Gill, P G, Walsh, J, Ward, G G

“…A programme of repeated high dose chemotherapy for advanced breast cancer was developed using (1) cyclophosphamide 4 g/m2 followed by autologous peripheral…”
Get more information

Primary central nervous system lymphoma. A report of 9 cases and review of the literature by Pittman, K B, Olweny, C L, North, J B, Blumbergs, P C

“…Primary central nervous system (CNS) lymphoma appears to be on the increase. This increase is real rather than due to changes in nosology, physician awareness…”
Get more information

Capecitabine and irinotecan (XELIRI) in first-line treatment of metastatic colorectal cancer (mCRC): A systematic review of controlled clinical trials by Sukumaran, S., Pavlakis, N., Pittman, K. B., Patterson, K., Price, T. J.

“…Abstract only e15100 Background: Irinotecan and 5-Fluorouracil based combination is an effective regimen for mCRC. Capecitabine, an oral fluoropyrimidine, is a…”
Get full text

Metastatic carcinoid tumour (MCT): 20 years experience at the Queen Elizabeth Hospital. Does management by a medical oncology unit (MOU) improve outcome? by Townsend, A. R., Yeend, S., Luke, C., Pittman, K. B., Patterson, K., Price, T. J.

“…Abstract only…”
Get full text

Rectal cancer: Pattern of care in the elderly by Kichenadasse, G., Townsend, A. R., Pittman, K. B., Patterson, K., Stephens, J. H., Borg, M., Rieger, N. A., Hewett, P. J., Rodda, D. J., Price, T. J.

“…Abstract only…”
Get full text

Mulicenter phase II study of gemcitabine and carboplatin combination therapy for patients with metastatic carcinoma of unknown primary site: final results by Pittman, K. B., Olver, I. N., Karapetis, C. S., Kotasek, D., Price, T. J., Patterson, W. K., Keefe, D. M., Koczwara, B., Parnis, F. X., Greer, D.

“…Abstract only…”
Get full text

Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells by Raynor, Michael, Stephenson, Sally-Anne, Walsh, David C A, Pittman, Kenneth B, Dobrovic, Alexander

“…Immunomagnetic enrichment followed by RT-PCR (immunobead RT-PCR) is an efficient methodology to identify disseminated carcinoma cells in the blood and bone…”
Get full text